Standards and Regulatory Considerations for Orthopaedic Implants

Similar documents
510(k) Summary for the Tiger Cannulated Screw System

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer

Paths to Market & FDA Product Lifecycle Regulation. Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005

~_Awl (99' ~.,..,~., ~.. FEDERAL EXPRES S. Cahill, Dear Mr.

The FDA/CDRH Perspective in the Regulation of Surgical Mesh

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: December 27, 2011

CBER Regulation of Devices for Cell Therapy

April 22, Trilliant Surgical, Limited Mr. J.D. Webb President The Orthomedix Group, Incorporated 1001 Oakwood Boulevard Round Rock, Texas 78681

To document the review procedures for a submission regarding compassionate/treatment use of investigational drugs, biologics and devices.

was published. February 21, 2017

March 6, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

Introduction to the FDA. Historical Context. Changes over Time FDA - BE-200 9/23/2004. Copyright C. S. Tritt, Ph.D. 1

Issues in Clinical Trial Designs for Devices

Guidance for FDA Reviewers

Corporate Medical Policy

RE: Docket No. FDA 2017 N 0041: Agency Information Collection Activities; Proposed Collection; Comment Request; Safety Assurance Case

FDA Regulation and Risk Assessment of Medical Devices

510(k) Summary NOV

Points to Consider for Marketing of Computerized Surgical Systems in the U.S.

Molecular Diagnostics: The Shift to Complexity. Molecular Diagnostics Regulation: Where do we go from here? David W Feigal, Jr.

Overview of ASTM Subcommittee F04.15 on Material Test Methods Terry O. Woods, Ph.D. FDA Center for Devices & Radiological Health

DEC DEPARTMENT OF HEALTH & HUMAN SERVICES

H-20 Page 1 of 5. Institutional Review Board Policy Manual HUMANITARIAN USE DEVICE (HUD) REQUIREMENTS

COVERAGE ELIGIBILITY OF SERVICES ASSOCIATED WITH A CLINICAL TRIAL

Wright Medical Group, Inc.

General Comments. May 30, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

US FDA: CMC Issues for INDs

Deciding When to Submit a 510(k) for a Change to an Existing Device Guidance for Industry and Food and Drug Administration Staff

FDA s Center for Devices and Radiological Health: Strategic Priorities for 2017 and Beyond

Tina Morrison, Ph.D. Chair, Committee on Modeling and Simulation Office of the Chief Scientist U.S. Food and Drug Administration

IMEDS: Sentinel and OMOP Programs Jane Reese-Coulbourne, MS, ChE Executive Director Reagan-Udall Foundation for the FDA

Draft Guidance for Industry, Clinical Laboratories, and FDA Staff. In Vitro Diagnostic Multivariate Index Assays

APR Dear Ms. Adair:

January 19, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

Draft Guidance for Industry and FDA Staff Premarket Notification [510(k)] Submissions for Medical Devices that Include Antimicrobial Agents

Re: Docket No. 2006D-0347, Federal Register: July 26, 2007 (Volume 72, Pages )

IMPROVE THE U.S. MEDICAL DEVICE REGULATORY PATHWAYS

Unique Device Identification: Convenience Kits Draft Guidance for Industry and Food and Drug Administration Staff

INVESTIGATIONAL DEVICE EXEMPTION APPLICATION. IDE Title (if title being used)

Medical Device Accessories: Defining Accessories and Classification Pathway for New Accessory Types. Draft Guidance for Industry and

UT SOUTHWESTERN MEDICAL CENTER AT DALLAS INSTITUTIONAL REVIEW BOARD. Emergency Use of an Investigational Drug, Biologic or Device

Oversight of Laboratory Developed Tests

DEPARTMENT OF HEALTH & HUMAN SERVICES

Guidance for Industry and FDA Staff Procedures for Handling Post-Approval Studies Imposed by PMA Order

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

Amarex Clinical Research Washington DC metro area A Product Development Services Company. From Lab to Market Approval

GUIDANCE FOR SPONSORS, INDUSTRY, RESEARCHERS, INVESTIGATORS, AND FOOD AND DRUG ADMINISTRATION STAFF

INVESTIGATIONAL DEVICE EXEMPTIONS AND EARLY FEASIBILITY STUDIES TO SUPPORT DEVICE INNOVATION

ANDREW BALO SENIOR VICE PRESIDENT, REGULATORY, BIOMETRICS, & CLINICAL AFFAIRS DEXCOM, INC 6340 SEQUENCE DRIVE SAN DIEGO, CA 92121

Guidance for Industry and FDA Staff. Replacement Reagent and Instrument Family Policy

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Document issued on: July 14, 2011

FDA Decisions for Investigational Device Exemption (IDE) Clinical Investigations

U.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE. Jeff Shuren Director Center for Devices and Radiological Health

February 22, Dear Dr. Cox:

Title: Review of Medical Devices Page: 1 of 5 Written by:

Navigating the FDA, and understanding Medical Device Preemption. Special Counsel Foulston Siefkin

Clinical Trials and Investigational Device Exemptions

Mark D. Kramer, RAC Regulatory Strategies, Inc.

De Novo Classification Process (Evaluation of Automatic Class III Designation) Guidance for Industry and Food and Drug Administration Staff

Docket No. FDA-2013-D-0114, Draft Guidance Distinguishing Medical Device Recalls From Product Enhancements; Reporting Requirements

Guidance for IRBs, Clinical Investigators and Sponsors

FDA identifies this generic type of device as: Absorbable perirectal spacer.

CDRH Device Approval

U.S. Food and Drug Administration (FDA) Regulatory Pathways for Medical Devices

MCW Office of Research Standard Operating Procedure

Draft Guidance for Industry and Food and Drug Administration Staff Class II Special Controls Guidance Document: External Pacemaker Pulse Generator

Request for Nominations for Individuals and Consumer Organizations for Advisory Committees

April 13, Background

An Introduction to the Worldwide Regulatory Framework for Medical Devices. Elizabeth Malo M.S., Director, Regulatory Affairs

Regulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC

STEPS TO APPLY FOR A NOVEL CPT CODE

JUN WARNING LETTER

Requirements for Humanitarian Use Device (HUD)

FDA Requirements for Clinical Investigations of Medical Devices: A Review for European Manufacturers

Contains Nonbinding Recommendations. Draft Not for Implementation

What do we need to realize in silico medicine in the future?

)Cot Y-9. Atrileu re~ 510(k) Summary JUN General Information. Classification Class 2

Disclosures. Laboratory Stakeholders. IVD vs. LDT. FDA Regulation of Laboratory Developed Tests 10/2/2015. FDA Regulation of LDTs

Medical Device Classification

October 13, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

Agenda: Opportunities in Developing Orphan Drug Products. Mukesh Kumar, PhD, RAC

A New Day in Orthopedic Devices. Proven Products + Highest Quality Manufacturing + Lowest Cost = WE WIN!

The In Vitro Diagnostic CRO

This letter corrects our substantially equivalent letter of November 25, 2014.

Investigational New Drug (IND) & Investigational Device Exemptions (IDE) Applications Preparation and Submission, and Conducting FDA Meetings

Deutsche Bank Health Care Conference

Board Meeting January 20, 2005 ROLL CALL PURCHASES

U.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE. Jeff Shuren Director Center for Devices and Radiological Health

Distinguishing Medical Device Recalls from Product Enhancements and Associated Reporting Requirements

Contains Nonbinding Recommendations. Draft Not for Implementation

ISO Orthopaedic drilling instruments Part 1: Drill bits, taps and countersink cutters

Guidance for Industry and FDA Staff

Clinical Study Design for Medical Devices

HUDs and HDEs: Common Misconceptions and Current Challenges. By Stephen P. Rhodes and Elisa D. Harvey, MS, PhD, DVM

November 9, AtriCure, Inc. Jonathan McElwee Regulatory Affairs Manager 7555 Innovation Way Mason, Ohio 45040

Safe Harbor Statement

INVITED REVIEW. William F. Pritchard, Jr, MD, PhD, Dorothy B. Abel, BS, and John W. Karanian, PhD, Rockville, Md

Exane BNP Paribas Conference 10 May 2010

Medical Device Regulatory Science: A View from 20 Years at FDA s Device Center

OSCILLATING SAW BLADES PAT. PENDING SPEZIAL TOOTHING

Transcription:

Standards and Regulatory Considerations for Orthopaedic Implants

Constituencies Patients Payers (Insurance) Physicians Manufacturers Research Community Government Legal Community

Professional Organizations Implant Companies Large (e.g. Zimmer, DePuy) Medium (e.g., Implex, Synthes) Small (e.g. Kinetikos) OSMA Research ORS SFB ASME ASB/ISB Physician Societies AAOS Committee on BME Specialty OTA AAHKS Hip Society AOFAS Device Forum Standards ASTM ISO Government FDA NIH/CDC/VA

Food and Drug Administration Charge: Ensure that all medical device products that are brought to market are safe and effective.

Statutory Authority Federal Food & Drugs Act of 1905 Upton Sinclair (The Jungle) et al. Theodor Roosevelt James Wilson Federal Food, Drug, & Cosmetic Act of 1938 Medical Device Amendment Act of 1976 May 28, 1976: Pre-Amendment Devices

FDA Device Classifications Class Description Examples I Minimum Risk Surgical instruments, Cast material, Crutches II Safety & Efficacy Information Exists Bone screws & plates, IM rods, Cemented THA III New Device Ligament replacements, Bone substitutes

FDA Evaluation Pathways Pre-Market Notification 510[k] Pre-Market Approval PMA Substantial equivalency to pre- Amendment or predicate device. Clinical and/or non-clinical testing. e.g.: design parameter changes New device or new intended use. Safety & efficacy data required, usually including clinical trials ($ $ $). Investigational Device Exemption IDE Clinical trials of new devices. Limited numbers, controlled settings, IRB & FDA approval. Not for commercial distribution

FDA Data Requirements Data Required 510 [k] PMA IDE General (e.g.name, description, materials, design, labeling, intended use) Yes Yes Yes Non-clinical data (e.g. bench tests, animal tests) Usually Yes Yes Clinical data Occasionally Yes When available

FDA Marketing Release Requirements Requirement Class I Class II?? $$ Class III 510 [k] Yes Yes No?? $$ PMA No No Yes IDE * No Sometimes Yes * Limited to participating trial center(s)

Guidance Documents Public Domain Suggested information that FDA needs Developed by FDA Staff Outside Experts Vetting Drafting Invited commentary from industry Heavy reliance on consensus standards (esp. ASTM)

Center for Devices and Radiological Health (CDRH) Rockville, MD 3,507 new products received marketing clearance in 2001 1,098 ongoing device trials 216 new clinical studies

Division of General, Restorative and Neurological Devices, CDRH Director Celia M. Witten, Ph.D., M.D. Deputy Director I Mark N. Melkerson Deputy Director II Miriam Provost Plastic & Reconstructive Surgery Devices Branch Stephen Rhodes General Surgery Devices Branch Neil R. Ogden Orthopedic Devices Branch Barbara Zimmerman 11 Staff Engineers Restorative Devices Branch Theodore Stevens

Orthopaedic and Rehabilitation Devices Panel EXEC SEC Hany Demian, M.S. Center for Devices and Radiological Health Office of Device Evaluation/DGRND CHAIRPERSON Michael J. Yaszemski, M.D., Ph.D. Senior Associate Consultant Dept. of Orthopedic Surgery Mayo Clinic and Graduate School of Medicine Maureen A. Finnegan, M.D. Associate Professor Dept. of Orthopaedic Surgery Univ. of Texas Southwestern Med Center Richard J. Friedman, M.D. Clinical Professor of Orthopaedic Surgery Medical University of South Carolina Kinley Larntz, Ph.D. Professor Emeritus Dept. of Applied Statistics University of Minnesota John S. Kirkpatrick, M.D. Associate Professor Dept. of Surgery, Div. of Orthopaedic Surgery Univ. of Alabama at Birmingham Stephen Li, Ph.D. President Institution Medical Device Testing and Innovations Sanjiv H. Naidu, M.D., Ph.D. Assistant Professor of Orthopaedic Surgery Dept. of Orthopaedics and Rehabilitation Pennsylvania State Univ., Hershey Medical Center Sally Maher, ESQ. INDUSTRY REPRESENTATIVE - Nonvoting Director, Regulatory Affairs & Clinical Research Smith & Nephew Richards Karen R. Rue CONSUMER REPRESENTATIVE - Nonvoting Director Quality Improvement Acadian Health Care Alliance

DIVISION OF GENERAL, RESTORATIVE, AND NEUROLOGICAL DEVICES Serves as the primary source for scientific and medical expertise on general surgery, plastic and reconstructive surgery, orthopedic and restorative devices with regard to safety and effectiveness. Performs, coordinates, directs and monitors all actions including scientific and medical review and evaluation for documents related to classification, petitions, premarket notification submissions (510(k)s), premarket approval applications (PMAs), product development protocols (PDPs), and investigational device exemptions (IDEs), and supplements or amendments to these submissions. Makes equivalence and nonequivalence determinations; approves or disapproves actions related to classification, petitions, 510(k)s, PMAs, PDPs, and IDEs, and all supplements and amendments to these submissions, as authorized. Provides executive secretarial support and other technical and nontechnical support to device advisory panels and panel members and consultants, and takes action on panel recommendations. Provides liaison, coordinates and takes action, as appropriate, on classification actions, petitions, 510(k)s, PMAs, PDPs, and IDEs with Center and agency components; Federal, State, and international agencies; and industry, consumer, and professional organizations.

American Society for Testing and Materials (ASTM)

ASTM Organized in 1898 Voluntary Standards Participants: Producers Users Consumers General Interest (Government, Academia) Coverage: Materials Products Systems Services

Uses for Standards Product R&D Manufacturing Quality Control Contracts & Purchase Agreements Scientific Protocols Regulatory Agencies Litigation

33,000 members ASTM 134 standards-writing committees Test methods, specifications, practices, guides, classifications, terminology Metals, paints, plastics, textiles, petroleum, construction, energy, environment, consumer products, electronics, medical devices, etc. 8,500 standards published per year Annual Book of ASTM Standards (68 vols)

134 Technical Committees, incl: F04 Medical & Surgical Materials & Devices 26 Subcommittees, incl: F04.21 Osteosynthesis F04.22 Arthroplasty 6 Task Groups: F04.21.01 Bone Screws F04.21.03 Intermedullary Rods F04.21.04 External Fixation Devices F04.21.05 Bone Staples F04.21.06 Wires & Cables F04.21.11 Bone Plates 26 Task Groups, incl: F04.22.04 Total Shoulder F04.22.06 Total Wrist F04.22.09 Femoral Stems F04.22.10 Hip Wear F04.22.11 Knee Wear F04.22.12 Tibial Trays F04.22.15 Femoral Head Finish

Standards Development Process Written request ASTM Staff Review Assignment to Committee Subcommittee Task Group F4 committee meets twice/year Document drafted by Technical Contact Informal revisions by Task Group members Task Group Recommendation Subcommittee Chairman approval to ballot Subcommittee Letter Ballot Main Committee Letter Ballot Editorial Review by ASTM Staff Publication ( 2-3 years) Negatives

ASTM Medical Devices Standards 391 Currently on the Books (Vol. 13) Classification Terminology Practice Guide Test Method Specification 5 Year Duration, Renewable